Finding treatments for Rheumatic Fever
ACT4RHD (Adaptive Collaborative Trial for Rheumatic Heart Disease) is an international adaptive platform trial evaluating new treatments to reduce heart inflammation and damage in children and young people with acute rheumatic fever.
A world-first platform Trial
ACT4RHD (Adaptive Collaborative Trial for Rheumatic Heart Disease) is an international adaptive platform trial evaluating new treatments to reduce heart inflammation and damage in children and young people with acute rheumatic fever.
A World-First Platform Trial
This world-first platform trial aims to identify effective treatments to reduce heart damage following acute rheumatic fever and improve health outcomes for children and young people.
Progress Through Partnership
Through this global collaboration we will advance the evidence needed to improve health outcomes for children and young people affected by acute rheumatic fever today and for future generations.
ACT4RHD is launching at participating hospitals in Aotearoa New Zealand and Australia.
International engagment is planned for 2027.
Menzies School of Health Research ACT4RHD team acknowledges the Larrakia Elders in Garramilla (Darwin) and Arrernte Elders in Mparntwe (Alice Springs), their people, and their country. We also acknowledge the people and the Elders of the Aboriginal and Torres Strait Islander Nations who are the Traditional Owners of the land and seas of Australia.
The University of Auckland and Starship Research ACT4RHD team acknowledge Māori as tangata whenua and Te Tiriti o Waitangi partners in Aotearoa New Zealand.
Join our mission. Volunteer, Donate, Advocate. Get Started Today.
Email: hello@divingo.com
Call Anytime: (235)-135-6213